Xebra Satisfies Conditions to Licence Unique Water-Soluble Cannabinoid Emulsion IP – Backed by Human Trials
Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
Synopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…
Synopsis: Pfizer’s JAK inhibitor Xeljanz and Novartis’ S1P modulator Gilenya both have their share of safety problems. But Vyne Therapeutics thinks it…
Summary : First and only FDA-approved medicine for TED, a serious, progressive, vision-threatening rare disease Clinical improvements were seen as early as…
Summary : Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor…
Synopsis : Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A…
Summary : Selecta Biosciences and Ginkgo Bioworks are extending their alliance to cover gene therapy delivery. Just months after disclosing a rare…